The reliability of compliance detection methods and practical strategies for improving patient compliance with drug therapy are reviewed. Detection of noncompliance is a necessary prerequisite for adequate treatment. Noncompliance can be detected by indirect methods (e.g., self-report, interview, therapeutic outcome, pill count, computerized compliance monitors) or direct methods (e.g., biologic markers, tracer compounds, biologic assay of body fluids). In general, the direct methods of detection have a higher sensitivity and specificity than the indirect methods. Computerized compliance monitors are the most recent and reliable of the indirect-detection methods. Strategies for improving compliance involve identification of risk factors for non-compliance; development, with the patient's participation, of an individualized treatment plan that simplifies the regimen as much as possible; education of the patient, including information about his or her illness, instructions on how to take the prescribed medication correctly, and an explanation of the benefits and possible adverse effects of the therapy; and, if necessary, use of compliance aids such as medication calendars, special containers, caps, and dispensing systems, or compliance packaging. The patient should be taught to monitor his or her own treatment regimen. Follow-up monitoring by health-care professionals, including pharmacists, will also help ensure that the patient is complying with the treatment regimen. Health-care practitioners need to understand factors that contribute to noncompliance and to use effective methods for assessing and monitoring compliance in conjunction with strategies aimed at increasing compliant behavior.

 

This article has been cited by other articles:

				J S Chatterjee From compliance to concordance in diabetes. J. Med. Ethics, September 1, 2006; 32(9): 507 - 510. [Abstract] [Full Text] [PDF]

				F Verdu and A Castello Non-compliance: a side effect of drug information leaflets J. Med. Ethics, December 1, 2004; 30(6): 608 - 609. [Full Text] [PDF]

				K. B Farris, J. M Ganther-Urmie, G. Fang, W. R Doucette, J. M Brooks, D. G Klepser, D. J Fries, and C. L Kuhle Population-Based Medication Reviews: A Descriptive Analysis of the Medication Issues Identified in a Medicare Not-for-Profit Prescription Discount Program Ann. Pharmacother., November 1, 2004; 38(11): 1823 - 1829. [Abstract] [Full Text] [PDF]

				S. F. Kemp, P. J. Fielder, K. M. Attie, S. L. Blethen, E. O. Reiter, K. M. Ford, M. Marian, L. N. Dao, H. J. Lee, and P. Saenger Pharmacokinetic and Pharmacodynamic Characteristics of a Long-Acting Growth Hormone (GH) Preparation (Nutropin Depot) in GH-Deficient Children J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3234 - 3240. [Abstract] [Full Text] [PDF]

				M. Tozawa, K. Iseki, C. Iseki, S. Oshiro, Y. Higashiuesato, M. Yamazato, N. Tomiyama, T. Tana, and S. Takishita Analysis of drug prescription in chronic haemodialysis patients Nephrol. Dial. Transplant., October 1, 2002; 17(10): 1819 - 1824. [Abstract] [Full Text] [PDF]

				J. M. Schectman, M. M. Nadkarni, and J. D. Voss The Association Between Diabetes Metabolic Control and Drug Adherence in an Indigent Population Diabetes Care, June 1, 2002; 25(6): 1015 - 1021. [Abstract] [Full Text] [PDF]

				E. O. Reiter, K. M. Attie, T. Moshang Jr., B. L. Silverman, S. F. Kemp, R. B. Neuwirth, K. M. Ford, and P. Saenger A Multicenter Study of the Efficacy and Safety of Sustained Release GH in the Treatment of Naive Pediatric Patients with GH Deficiency J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4700 - 4706. [Abstract] [Full Text] [PDF]

				H.-Y. Huang, M. G. Maguire, E. R. Miller III, and L. J. Appel Impact of Pill Organizers and Blister Packs on Adherence to Pill Taking in Two Vitamin Supplementation Trials Am. J. Epidemiol., October 15, 2000; 152(8): 780 - 787. [Abstract] [Full Text] [PDF]

				R. Sherer Adherence and Antiretroviral Therapy in Injection Drug Users JAMA, August 12, 1998; 280(6): 567 - 568. [Full Text] [PDF]

				N. H. Miller, M. Hill, T. Kottke, and I. S. Ockene The Multilevel Compliance Challenge: Recommendations for a Call to Action: A Statement for Healthcare Professionals Circulation, February 18, 1997; 95(4): 1085 - 1090. [Full Text]

				D. Borowitz, T. Wegman, and M. Harris Preventive Care for Patients With Chronic Illness: Multivitamin Use in Patients With Cystic Fibrosis Clinical Pediatrics, December 1, 1994; 33(12): 720 - 725. [Abstract] [PDF]